NO20043447L - Fremgangsmate for fremstilling av 3-(2-(4-(6-fluorbenzo(D)isoksazol-3-yl)-piperidin- l yl)-etyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-A)pyrimidin-4-on - Google Patents

Fremgangsmate for fremstilling av 3-(2-(4-(6-fluorbenzo(D)isoksazol-3-yl)-piperidin- l yl)-etyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-A)pyrimidin-4-on

Info

Publication number
NO20043447L
NO20043447L NO20043447A NO20043447A NO20043447L NO 20043447 L NO20043447 L NO 20043447L NO 20043447 A NO20043447 A NO 20043447A NO 20043447 A NO20043447 A NO 20043447A NO 20043447 L NO20043447 L NO 20043447L
Authority
NO
Norway
Prior art keywords
fluorobenzo
isoxazol
pyrido
piperidin
tetrahydro
Prior art date
Application number
NO20043447A
Other languages
English (en)
Inventor
Rafael Foguet
Jorge Ramentol
Ines Petschen
Francesc X Camps
Miguel P Armengol
Diego Fernandez-Cano
Juan Sallares
Mireia Pasto
Esther Gordo
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20043447L publication Critical patent/NO20043447L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20043447A 2002-03-05 2004-08-18 Fremgangsmate for fremstilling av 3-(2-(4-(6-fluorbenzo(D)isoksazol-3-yl)-piperidin- l yl)-etyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-A)pyrimidin-4-on NO20043447L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200531A ES2197801B1 (es) 2002-03-05 2002-03-05 Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
PCT/EP2003/002157 WO2003074522A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one

Publications (1)

Publication Number Publication Date
NO20043447L true NO20043447L (no) 2004-08-18

Family

ID=27772022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043447A NO20043447L (no) 2002-03-05 2004-08-18 Fremgangsmate for fremstilling av 3-(2-(4-(6-fluorbenzo(D)isoksazol-3-yl)-piperidin- l yl)-etyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-A)pyrimidin-4-on

Country Status (22)

Country Link
US (1) US7205405B2 (no)
EP (1) EP1480978A1 (no)
JP (1) JP2005525366A (no)
KR (1) KR100680003B1 (no)
CN (1) CN1315826C (no)
AU (1) AU2003219010A1 (no)
BR (1) BR0308139A (no)
CA (1) CA2474811A1 (no)
CO (1) CO5611140A2 (no)
CR (1) CR7462A (no)
ES (1) ES2197801B1 (no)
IL (1) IL163750A0 (no)
MA (1) MA26353A1 (no)
MX (1) MXPA04008289A (no)
NO (1) NO20043447L (no)
NZ (1) NZ534463A (no)
PL (1) PL370502A1 (no)
RU (1) RU2272037C9 (no)
TN (1) TNSN04139A1 (no)
UA (1) UA80114C2 (no)
WO (1) WO2003074522A1 (no)
ZA (1) ZA200405939B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0214716B8 (pt) * 2001-12-05 2021-05-25 Teva Womens Health Inc kit, preparos, e uso de estrogênio e progestina na fabricação de um medicamento para uso na prevenção de gravidez
KR20040025224A (ko) * 2002-09-18 2004-03-24 주식회사 대웅 2-(2-메틸-4-옥소-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-3-일)아세트알데히드 및 그 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
CZ295402B6 (cs) * 2000-05-05 2005-08-17 Rpg Life Sciences Limited Způsob přípravy antipsychotického 3-[2-[4-(6-fluor-1,2-benzizoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-onu

Also Published As

Publication number Publication date
MXPA04008289A (es) 2004-11-26
MA26353A1 (fr) 2004-10-01
IL163750A0 (en) 2005-12-18
NZ534463A (en) 2006-02-24
JP2005525366A (ja) 2005-08-25
KR100680003B1 (ko) 2007-02-08
UA80114C2 (en) 2007-08-27
ES2197801A1 (es) 2004-01-01
ES2197801B1 (es) 2005-03-16
CA2474811A1 (en) 2003-09-12
WO2003074522A1 (en) 2003-09-12
PL370502A1 (en) 2005-05-30
KR20040091679A (ko) 2004-10-28
CR7462A (es) 2005-02-10
ZA200405939B (en) 2006-06-28
RU2272037C1 (ru) 2006-03-20
CN1315826C (zh) 2007-05-16
BR0308139A (pt) 2005-01-04
CN1639163A (zh) 2005-07-13
TNSN04139A1 (en) 2007-03-12
US7205405B2 (en) 2007-04-17
CO5611140A2 (es) 2006-02-28
RU2272037C9 (ru) 2006-06-20
US20050143395A1 (en) 2005-06-30
AU2003219010A1 (en) 2003-09-16
EP1480978A1 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
NZ598220A (en) Heterocyclic compounds and uses thereof
ATE284214T1 (de) Imidazo(1,2-a)-pyridinderivate als mglur5 antagonisten
HK1117521A1 (en) Process for preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3- yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h- pyrido[1,2-a]pyrimidin-4-one palmitate ester
LTPA2017013I1 (lt) 2-(Piridin-2-ilamino)-pirido[2,3-d]piridin-7-onai
NZ599932A (en) Imidazopyridine derivatives as jak inhibitors
JP2005525324A5 (no)
JP2006503010A5 (no)
JP2006524254A5 (no)
NO20045002L (no) (1-4-piperidinyl) benzimidazolderivater som kan anvendes som histamin H3-antagonister
IL172266A0 (en) Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
RU2003106193A (ru) Способ лечения аллергий с использованием замещенных пиразолов
WO2009118655A3 (en) Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
NZ599281A (en) Cgrp receptor antagonists
Rowley et al. 4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor
JP2013515032A5 (no)
NO20080033L (no) Kinolinderivater som NK3-antagonister
DK1611144T3 (da) Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister
JP2010508328A5 (no)
JP2009520018A5 (no)
BRPI0905938A2 (pt) processo para preparação de 3-(2 cloroetil)- 2- metil hidróxi- 4h-pirido [l, 2-a] pirimidina-4- ona, de 3- (2-cloroetil)-6,7,8,9- tetraidro 9- hidróxil-2-metil-4h-pirido[1,2-a]pirimidina-4-ona, de 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-il)-1-piperidinil]etil]-6,7,8,9-tetaidro-9-hidróxi-2-metil-4h-pirido[1,2-a]pirimidina-4-ona bruta, e processo para a purificação da paliperidona
JPH09315973A (ja) 特定の４−アリール−５−カルバモイル−１，４−ジヒドロピリジンを含む医薬組成物
AU702931B2 (en) Antipsychotic 4-(1H-indolyl-1-yl)-1-substituted piperidine derivatives
AU2002356251A1 (en) 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereof
NO20043447L (no) Fremgangsmate for fremstilling av 3-(2-(4-(6-fluorbenzo(D)isoksazol-3-yl)-piperidin- l yl)-etyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2-A)pyrimidin-4-on
RU2340612C2 (ru) 2-имидазобензотиазолы как лиганды аденозинового рецептора

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application